(3S,6S,7R)-N-benzhydryl-7-((3S)-1-((3S,6S,7S)-7-(hydroxymethyl)-6-((R)-2-(methylamino)butanamido)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepin-3-yl)-1,4,18,22-tetraoxo-3-phenyl-8,11,14,20-tetraoxa-2,5,17,23-tetraazatetracosan-24-yl)-6-((R)-2-(methylamino)butanamido)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxamide di-2,2,2-trifluoroacetate (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (3S,6S,7R)-N-benzhydryl-7-((3S)-1-((3S,6S,7S)-7-(hydroxymethyl)-6-((R)-2-(methylamino)butanamido)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepin-3-yl)-1,4,18,22-tetraoxo-3-phenyl-8,11,14,20-tetraoxa-2,5,17,23-tetraazatetracosan-24-yl)-6-((R)-2-(methylamino)butanamido)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxamide di-2,2,2-trifluoroacetate's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	(3S,6S,7R)-N-benzhydryl-7-((3S)-1-((3S,6S,7S)-7-(hydroxymethyl)-6-((R)-2-(methylamino)butanamido)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepin-3-yl)-1,4,18,22-tetraoxo-3-phenyl-8,11,14,20-tetraoxa-2,5,17,23-tetraazatetracosan-24-yl)-6-((R)-2-(methylamino)butanamido)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxamide di-2,2,2-trifluoroacetate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Baculoviral IAP repeat-containing protein 2 Protein (Entity type)	IC50
	(3S,6S,7R)-N-benzhydryl-7-((3S)-1-((3S,6S,7S)-7-(hydroxymethyl)-6-((R)-2-(methylamino)butanamido)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepin-3-yl)-1,4,18,22-tetraoxo-3-phenyl-8,11,14,20-tetraoxa-2,5,17,23-tetraazatetracosan-24-yl)-6-((R)-2-(methylamino)butanamido)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxamide di-2,2,2-trifluoroacetate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	E3 ubiquitin-protein ligase XIAP Protein (Entity type)	IC50